This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Rye Brook, NY, Xylem Inc. is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. It has significant presence in the United States, the Asia Pacific, Europe and various other nations. The company reports business operations under three segmental heads — Water Infrastructure, Sensus and Applied Water.
Key Reasons to Retain the Howmet (HWM) Stock in Your Portfolio
by Zacks Equity Research
Continued recovery in the commercial aerospace end market bodes well for Howmet (HWM). The company's healthy margin performance due to cost-control measures and pricing actions are encouraging.
Honeywell (HON) Introduces Ethanol-to-Jet Fuel Technology
by Zacks Equity Research
Honeywell's (HON) new ethanol-to-jet fuel technology, which can substantially reduce greenhouse gas emissions, is aimed at meeting the growing demand for SAF.
Ingersoll Rand (IR) Acquires Dosatron International for $90M
by Zacks Equity Research
Ingersoll Rand's (IR) Dosatron acquisition expands its digital technology portfolio, opening up opportunities in hydroponics, horticulture and water treatment end markets.
Is Invesco S&P 500 Equal Weight Industrials ETF (RGI) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RGI
Xylem (XYL) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Xylem (XYL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Is Xylem (XYL) Down 6.4% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Up 13% in 6 Months: Will the Momentum Continue?
by Zacks Equity Research
Strong demand across end markets, solid backlogs and orders are aiding Xylem's (XYL) performance. The company's consistent measures to reward its shareholders are encouraging.
Xylem (XYL) Beats on Q2 Earnings, Improves 2022 Guidance
by Zacks Equity Research
Xylem's (XYL) Q2 results benefit from strong demand across its end markets and record backlog and order levels. The company raises its 2022 view owing to strong demand and better price realization.
Xylem (XYL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 20% and 4.58%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Industrial Stocks Poised to Trump Q2 Earnings Estimates
by Eshani Haque
End-market strength is likely to have aided the second-quarter 2022 performances of MRC Global (MRC), Xylem (XYL), Zebra Technologies (ZBRA) and Eaton (ETN), partly offset by supply chain woes.
Parker-Hannifin (PH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Parker-Hannifin (PH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Supply Chain & Cost Woes Mar Xylem's (XYL) Q2 Earnings?
by Zacks Equity Research
While supply chain restrictions and raw material cost inflation are likely to have hurt Xylem's (XYL) Q2 performance, solid backlog level and effective pricing is expected to have aided the same.
Strength Seen in Graham (GHM): Can Its 7.4% Jump Turn into More Strength?
by Zacks Equity Research
Graham (GHM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Xylem (XYL) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Xylem (XYL) stands to gain from strength in its businesses, solid backlog level and shareholder-friendly policies. Escalating costs and expenses and high debt levels weigh on it.
Xylem (XYL) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Exhibits Strong Prospects, Headwinds Remain
by Zacks Equity Research
Xylem (XYL) is poised to gain from strength in its businesses, solid backlog level and shareholder-friendly policies. High costs and expenses, along with supply-chain challenges, weigh on it.
Xylem (XYL) Q1 Earnings Top Estimates, Supply Woes Hurt
by Zacks Equity Research
Xylem's (XYL) Q1 earnings reflect the impacts of the weak Measurement & Control Solutions segment and supply-chain woes.
Xylem (XYL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 11.90% and 3.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Xylem's (XYL) Q1 earnings are likely to have benefited from strength across its businesses. Supply-chain challenges and cost inflation might have been spoilsports.
Chart Industries (GTLS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Chart Industries (GTLS) delivered earnings and revenue surprises of 8.77% and 0.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Xylem (XYL) Q1 Earnings Expected to Decline
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) Tops Q4 Earnings Estimates, Hurt by Supply Woes
by Zacks Equity Research
Xylem's (XYL) Q4 earnings reflect the impacts of the weak Measurement & Control Solutions segment and supply-chain woes. It expects 1H22 performance to suffer from supply woes.
Xylem (XYL) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 1.61% and 2.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
IDEX (IEX) Lags on Q4 Earnings, Projects Y/Y Growth for 2022
by Zacks Equity Research
IDEX's (IEX) Q4 earnings reflect the impacts of strength in segmental businesses and synergies from acquired assets. It predicts year-over-year growth in earnings per share for 2022.